These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6619618)

  • 1. [Treatment of intractable ascites at the terminal stage of ovarian carcinoma--reinfusion of the cell-free, concentrated ascitic fluid].
    Kitao M; Takahashi K; Iwaka O
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1668-71. PubMed ID: 6619618
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of intractable ascites by continuous reinfusion of the sterilized, cell-free and concentrated ascitic fluid.
    Inoue N; Yamazaki Z; Oda T; Sugiura M; Wada T
    Trans Am Soc Artif Intern Organs; 1977; 23():699-702. PubMed ID: 910402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of resistant ascites by continuous ultrafiltration--reinfusion of ascitic fluid.
    Villeneuve JP; Thuot C; Marleau D; Joly JG; Huet PM; Viallet A
    Can Med Assoc J; 1977 Dec; 117(11):1296-8. PubMed ID: 72594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinfusion of autogenous ascitic fluid concentrated by freezing in patients with intractable ascites.
    Chiyoda S; Morikawa T; Matsuo K; Masuya S
    Intern Med; 1992 Mar; 31(3):325-32. PubMed ID: 1611182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cell-free and concentrated ascites reinfusion therapy(CART)].
    Yoshizawa A; Gyouda Y; Ishiguro T; Matsuzaki K; Yoshizawa T
    Gan To Kagaku Ryoho; 2012 Dec; 39 Suppl 1():33-5. PubMed ID: 23268893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic dilemma in an elderly woman with intractable ascites and elevated CA-125 level.
    Gupta S; Maheshwari A; Wuntkal R; Mazid T; Tongaonkar HB
    J Assoc Physicians India; 2006 Aug; 54():655-6. PubMed ID: 16941798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of cancer ascites by combined intraperitoneal administration of low-dose CDDP and reinfusion of ultra-filtrated and concentrated ascitic fluid in patients].
    Takahashi Y; Imai H; Ikawa A; Yasuda K; Kawai M; Yamamori T; Furuichi N; Misawa K; Ohashi H
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1820-4. PubMed ID: 10560403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
    Zaak D; Paquet KJ; Kuhn R
    Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ileo-entectropy for ascites associated with ovarian tumors.
    McCann WJ; Cappelletti RR; Neumann CG
    Obstet Gynecol; 1968 Oct; 32(4):482-7. PubMed ID: 5742460
    [No Abstract]   [Full Text] [Related]  

  • 11. [Personal experience with the reinfusion of concentrated ascitic fluid in liver cirrhosis].
    Cervinka J; Kordac V; Benes R
    Cas Lek Cesk; 1983 Mar; 122(10):302-5. PubMed ID: 6839336
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in biochemical data in ascites and serum before and after the treatment of intractable ascites for patients with terminal gynecologic tumor: re-infusion of cell-free and concentrated ascitic fluid.
    Takahashi K; Shibukawa T; Moriyama M; Kitao M
    Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2097-103. PubMed ID: 4093686
    [No Abstract]   [Full Text] [Related]  

  • 13. [Concentration-reinfusion methods in intractable ascites caused by liver cirrhosis. Importance of monitoring plasma renin activity and urinary sodium].
    D'Amore V; Maestri G; Prandi GC
    Minerva Dietol Gastroenterol; 1985; 31(2):317-21. PubMed ID: 2412186
    [No Abstract]   [Full Text] [Related]  

  • 14. Single center experience of cell-free and concentrated ascites reinfusion therapy in malignancy related ascites.
    Ito T; Hanafusa N; Fukui M; Yamamoto H; Watanabe Y; Noiri E; Iwase S; Miyagawa K; Fujita T; Nangaku M
    Ther Apher Dial; 2014 Feb; 18(1):87-92. PubMed ID: 24499089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of appropriate flow rate settings for cell-free and concentrated ascites reinfusion therapy and change of cytokine concentrations in ascites.
    Orimi S; Mizuno K; Narahara M; Umakosi H; Kaihara M; Hashimoto M
    Ther Apher Dial; 2011 Aug; 15(4):411-4. PubMed ID: 21884478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.
    Maeda S; Yabuuchi J; Nobuta H; Makiishi T; Hirose K
    Ther Apher Dial; 2015 Aug; 19(4):342-8. PubMed ID: 26386222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New experiences on treatment of ascites in the Morgagni-Laënnec cirrhosis by means of reinfusion of autogenous ascitic fluid].
    Barlattani M; Alessandrini A; Vecchi L
    Clin Ter; 1965 Aug; 34(3):210-28. PubMed ID: 5849857
    [No Abstract]   [Full Text] [Related]  

  • 18. [The reinfusion of ascitic fluid into patients with liver cirrhosis and ascites resistant to drug treatment].
    Kotsev I; Bozhanin D; Martev P; Deliĭski M; Baĭcheva M
    Vutr Boles; 1989; 28(4):93-6. PubMed ID: 2596115
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reinfusion of ascitic fluid in the treatment of ascites in patients with liver cirrhosis].
    Zhuravlev VA; Sukhorukov VP; Shishkin BA
    Sov Med; 1983; (2):95-7. PubMed ID: 6857357
    [No Abstract]   [Full Text] [Related]  

  • 20. [A patient with stage IIIc ovarian cancer with massive ascites who was chemotherapy resistant showed complete response with intraperitoneal hyperthermic chemoperfusion].
    Kobayashi K; Fujimoto S; Takahashi M; Mutou T; Toyosawa T; Ohtsuka Y; Ogasawara T
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1726-8. PubMed ID: 14619504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.